MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) to Provide Update on Heart Failure Clinical Trial at BIOX; Noble Financial Capital Markets' Life Sciences Exposition
SAN DIEGO--(BUSINESS WIRE)--Medistem Inc (Pink Sheets:MEDS), a clinical stage adult stem cell company, today announced that its CEO Dr. Thomas Ichim will attend and present at BIOX; Noble Financial Capital Markets’ Life Sciences Exposition to be held at the University of Connecticut, Stamford Campus on September, 24th at 9 AM.